Xylazine: What we Know, What we Don’t, and What we Can do Now – MCBAP/CME/Social Work CEU Credits Approved (DEA Training)

Please join the Michigan Opioid Collaborative for a presentation and discussion on xylazine. This talk will cover the prevalence and epidemiology of xylazine in the unregulated drug supply, lay out what is currently known about xylazine and its unintentional use, and highlight actionable and high-yield harm reduction strategies that can be incorporated into practice. Q&A and discussion to follow.

1 Available Credit – Meets DEA SUD Training Requirements:

• MCBAP credit approved
• Social Work CEU credit approved
• CME credit approved

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of MyMichigan Health and Michigan Opioid Collaborative. MyMichigan Health is accredited by the Michigan State Medical Society to provide continuing medical education for physicians. MyMichigan Health designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity. This training meets the new DEA SUD training requirements.

Presenter:

• Claire Zagorski, MSc, LP

Register Here:

Click here or scan the QR Code below to register for this webinar!

We hope to see you there!

Want to share this event? Download our flyer for this event and pass it along.